Manufacturers Life Insurance Company, The Heron Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 44,512 shares of HRTX stock, worth $47,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,512
Previous 45,771
2.75%
Holding current value
$47,627
Previous $160,000
45.0%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding HRTX
# of Institutions
180Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$28.6 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$9.47 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$9.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$8.91 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$7.48 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $127M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...